Humanigen, Inc. HGEN
Set alert
0.00 USD 0.00 0.00%
As of Jan 4, 1:45 PM ET
0.0001 Day range 0.0005
0.0001 52-week range 0.239
- Open
- 0.0005
- Prev close
- 0.0002
- Mkt cap
- 0
- Vol
- 2.06M
- Avg vol
- 341.85K
- EPS
- -0.51
- P/E
- -0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0005
- Forward P/E
- 0.00
- Beta
- 0.00
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 1, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
3M chart
Signals (11)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Jan 18, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 8, 2024 | 2 years ago |
| SMA: Bearish | Jan 4, 2024 | 2 years ago |
| SMA: Bearish | Jan 4, 2024 | 2 years ago |
| SMA: Bullish | Jan 2, 2024 | 2 years ago |
| SMA: Bearish | Dec 29, 2023 | 2 years ago |
| SMA: Bullish | Dec 29, 2023 | 2 years ago |
| SMA: Bullish | Dec 28, 2023 | 2 years ago |
| SMA: Bearish | Dec 6, 2023 | 2 years ago |
| SMA: Bullish | Nov 29, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 2, 2023 | 3 years ago |
Key statistics
- Market cap
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- Price / sales
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Jan 1, 2024
Expected Jan 1, 2024. Consensus EPS estimate 0.00.
Financials — quick view
HGEN Revenue — quarterly 221.00K
HGEN Net income — quarterly -4.18M
HGEN EPS — quarterly -0.04
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Jan 1, 2024 | Sep 1, 2023 | 0.00 | — | — | — |
| Oct 6, 2023 | Jun 1, 2023 | 0.00 | — | — | — |
| Nov 14, 2022 | Sep 1, 2022 | -0.21 | — | — | — |
| Aug 12, 2022 | Jun 1, 2022 | -0.34 | — | — | — |
News
- US says former Humanigen chief scientific officer charged with insider trading
- Levi & Korsinsky, LLP Notifies Shareholders of Humanigen, Inc. (HGEN) an Upcoming Claims Deadline in a Class Action Settlement
- Levi & Korsinsky, LLP Notifies Shareholders of Humanigen, Inc. (HGEN) an Upcoming Claims Deadline in a Class Action Settlement
- HGEN Stock Alert: Why Humanigen Just Filed for Ch. 11 Bankruptcy
- COVID-19 treatment developer Humanigen files for Chapter 11 bankruptcy
- Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation
- Humanigen stock removed from S&P Total Market Index as firm faces bankruptcy
- 12 Health Care Stocks Moving In Tuesday's Intraday Session
- Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Tuesday
Your note
Sign in to keep a note on HGEN — it syncs with the Stock Master app.